The Cannigma

JANUARY 16, 2021

When you walk into a hardware store, pharmacy, or even a liquor store, if you don’t know exactly what product will meet your needs there’s someone educated enough to point you to the right product and the data to back up that recommendation, says Tyler Dautrich, COO of Releaf. Edited and mixed by Michael Schaeffer Omer-Man.

Data 100

Data Research and Development Patients Strains 100

Cannabis Law Report

DECEMBER 8, 2021

Access to headline, upfront, milestone and royalty data. Access to hundreds of Psychiatry deal contract documents. Comprehensive access to over 780 Psychiatry deal records. Under what conditions can the deal be terminated? Access Psychiatry deal headline, upfront, milestone and royalty data.

Access 52

Access Data Pharmaceutical Research and Development 52

NORML

JUNE 10, 2020

The agency’s call for comments, initially posted on April 17 at regulations.gov here , states: “Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management. percent in 2016).”

Chronic Pain 239

Chronic Pain Therapy Patients Topical 239

SpeedWeed

MARCH 14, 2021

Big data and technology have become critical to a wide variety of industries in recent years, and the cannabis industry is no exception. Through advanced data collection and the application of sophisticated algorithms, usable data is now available to help marijuana businesses: Predict trends. Met consumer demands. Reduce costs.

Data 52

Data Research and Development Marijuana Collective 52

MMJ Recs

MAY 3, 2024

With its program in full swing, thousands of patients across the state are benefiting from access to this alternative form of treatment. From chronic pain to PTSD, patients with qualifying medical conditions have found solace in medical marijuana where traditional treatments may have fallen short.

Marijuana 52

Marijuana Treatment Compliance Compliance 52

Cannabis Law Report

DECEMBER 11, 2021

The UK’s first and highest-rated medical cannabis clinic, Sapphire Medical Clinics , has today announced that it is reducing the cost of its consultations and appointments for patients enrolled through the Sapphire Access Scheme. The Sapphire Access Scheme will be open to an additional 2,000 patients in the UK.

Access 52

Access Patients Chronic Pain Treatment 52

Cannabis Law Report

AUGUST 23, 2022

For more than a year, the Department of Health has fought to keep that information secret. Spotlight PA sought that data to better understand the impact of the agency’s unusual and controversial decision to endorse cannabis as a treatment option for opioid use disorder. The Department of Health still refused to provide the information.

Data 52

Data Treatment Patients Chronic Pain 52

NORML

MAY 26, 2020

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Additional information regarding cannabinoids and pain appears online h ere.

Clinical Trials 249

Clinical Trials Chronic Pain Cannabinoids Patients 249

Cannabis Law Report

AUGUST 20, 2022

CHICAGO — Governor JB Pritzker and the Illinois Department of Financial and Professional Regulation (IDFPR) today issued three additional Conditional Adult Use Dispensing Organization Licenses to applicants selected in lotteries held in the summer of 2021. Additional information on these resources and how to access them can be found here.

Conditions 52

Conditions Dispensary Programs Business 52

NORML

JANUARY 31, 2019

Seventy-five percent of military veterans say that they would consider using either “cannabis or cannabinoid products as a treatment option,” according to member survey data compiled by the group Iraq and Afghanistan Veterans of America (IAVA). The organization represents over 400,000 veterans nationwide.

Clinical Trials 189

Clinical Trials Chronic Pain Data Treatment 189

Medicinal Marijuana Association

FEBRUARY 10, 2024

With over 100 known cannabinoids in cannabis, staying informed about the latest research is crucial for making informed decisions. However, by following a strategic guide, you can stay ahead of the curve and make informed choices regarding cannabis use. Differentiate between fact and fiction by accessing trustworthy information.

Research and Development 52

Research and Development Data Chronic Pain Conditions 52

NORML

NOVEMBER 25, 2019

Patients suffering from persistent pain conditions who frequently use cannabis are far less likely to use non-prescription opioids, according to longitudinal data published in the journal PLOS One. Additional information is available from the NORML fact-sheet , ‘Relationship Between Marijuana and Opioids.’

Chronic Pain 280

Chronic Pain Patients Therapy Data 280

Cannabis Law Report

AUGUST 14, 2019

Let’s take a closer look at five key ways big data and technology are directly impacting the industry. Big Data Streamlines the Marijuana Regulatory Process and Helps Close the Scientific Research Gap. Therefore, the growing marijuana market lacks the clinical data needed to help marijuana businesses create new and better products.

Data 45

Data Research and Development Marijuana Collective 45

Cannabis Law Report

AUGUST 23, 2021

The TGA recently released a new medical cannabis dashboard detailing a variety of information on both SAS-A and SAS-B approvals. They announced that they’re ‘committed to ongoing transparency and will release additional datasets in the future’, such as data on Authorised Prescriber applications and the concentrations of active ingredients.

Chronic Pain 105

Chronic Pain Concentrates Conditions Data 105

Veriheal

FEBRUARY 9, 2023

The data collected so far by the Turner Institute for Brain and Mental Health at Monash University in Australia suggests that psilocybin not only makes the process more comfortable but, as one participant described, MRIs become “magical.” All imaging and behavioral data will be accessible to the public after the study is complete.

Clinical Trials 98

Clinical Trials Research and Development Data Collective 98

Cannabis Law Report

JUNE 23, 2021

Medicann is a premier cannabis-specialized clinic, providing patients with access to local specialist doctors and pharmacists that have experience prescribing cannabis-based medication. With a strong IP portfolio, RYAH gathers deep and insightful data on the complete patient session and formulation life cycle. About RYAH Group, Inc.

Programs 100

Programs Data Events Collective 100

Cannabis Law Report

JUNE 1, 2021

Given the size and scale of the study, RYAH has developed a custom software solution, using OAuth API-integration to protect the privacy of the participants in the study, with the goal of enabling a fully integrated, patient feedback and data collection capability. About RYAH Group, Inc. RYAH Group, Inc.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Veriheal

DECEMBER 14, 2023

Study Results The study, published in CNS Drugs, tested 40 participants on their ability to complete neurological-based tests on pattern recognition, multitasking, reaction time, information processing, and working memory.

Chronic Pain 120

Chronic Pain Consumption Cannabis Marijuana 120

Cannabis Law Report

JULY 5, 2021

information comes available such as supplier pricing, stock changes, running costs, accounting. The ERP operates as a system, collecting data in real time and connecting it all together for your. Access Control. Since the ERP is equipped with all of the company’s information, the access to data is controlled.

Pharmaceutical 111

Pharmaceutical Data Access Business 111

Cannabis Law Report

MAY 10, 2022

More than half of all prescriptions for medicinal cannabis in Australia are written by doctors in Queensland, with prescriptions often given for conditions there is little evidence medicinal cannabis can treat, new research reveals. The researchers’ analysis found anxiety was the reason given for 16% of medicinal cannabis prescriptions.

Medicine 52

Medicine Clinical Trials Data Sleep 52

Veriheal

AUGUST 17, 2022

Data that’s been published on the subject have been contradictory. The population-based cohort study used data from the Ontario portion of the 2009-2010 and 2011-2012 Canada Community Health Survey (CCHS). Missing and Vague Information. The Study Appears to Have a Few Flaws. Localized, Small Sample Size.

Research and Development 104

Research and Development Topical Data Cannabis 104

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 billion (USD $2 billion).

Consumption 109

Consumption Patients Research and Development Data 109

MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions. Image by Pfüderi from Pixabay.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Veriheal

AUGUST 15, 2022

The condition may also occur as a result of poor lifestyle habits, chronic disease, and depression. Highly rated by users, the Releaf App features an electronic diary that can be updated with information pertaining to self-monitored cannabis session-specific effects. The Releaf App’s Role in the Fatigue Study.

Treatment 96

Treatment Research and Development Sativa Cannabinoids 96

The Cannigma

MARCH 14, 2023

Cancer, HIV, epilepsy and other serious conditions were the first accepted uses of cannabis in the United States. Many of the early medical cannabis states had strict lists of conditions for which cannabis could be legally used. And the process of adding additional conditions was often lengthy, difficult and mired in paternalism.

Policy 96

Policy Research and Development Conditions Consumption 96

Cannabis Law Report

AUGUST 2, 2021

The nearly 3,000 participant study will capture and publish the most comprehensive data ever collected on CBD product effectiveness from 13 commercially available U.S. Radicle ACES is Institutional Review Board (IRB) approved and will capture CBD effectiveness data directly from nearly 3,000 study participants.

CBD 105

CBD Data Sleep Clinical Trials 105

Cannabis Law Report

AUGUST 24, 2022

New research from the University of Sydney’s Lambert Initiative finds most Australians are still medicating with illicit cannabis, although numbers accessing prescription products have risen dramatically. People using illicit products were more likely to be treating mental health or sleep conditions.

Medicine 52

Medicine Legalization Chronic Pain Access 52

Veriheal

MARCH 29, 2023

In addition, several other studies suggest that legalizing access to marijuana is actually associated with decreased: Crime Opioid overdose Mental illness rates Gone are the days when cautionary tales run rampant. How Several Sources of Data Were Used in the Research In 2019, an estimated 48.2 1, 2003, to Dec. 1, 2003, to Dec.

Legalization 57

Legalization Data Policy Cannabis 57

Cannabis Law Report

SEPTEMBER 7, 2022

Since the legalisation of medical cannabis in the UK in 2018, there is little education surrounding medical cannabis and how it can help a large variety of conditions, should traditional medicine leave patients with an ‘unmet clinical need.’ . Cantourage Clinic is a leading medical cannabis clinic in the UK with a difference. .

Patients 52

Patients Conditions Treatment Education 52

Veriheal

DECEMBER 9, 2021

Those who support cannabis have used the evidence of its ability to treat mental conditions like post-traumatic stress disorder (PTSD) to rebuke claims of a link between cannabis and mental illness. We found that recreational marijuana access was associated with a 6.29 Support From Other Studies. Singer et al.

Legalization 98

Legalization Research and Development Consumption Recreational 98

Cannabis Law Report

DECEMBER 9, 2021

“Partnering with Fyllo reinforces our commitment to delivering innovative data solutions designed to enhance our clients’ audience reach strategies,” said Jay Baum , Chief Commercial Officer at Tremor Video. Learn more about Tremor Video’s data-driven audience solutions at www.tremorvideo.com. Traditional segments (e.g.

CBD 52

CBD Data Compliance Compliance 52

Cannabis Law Report

JULY 6, 2021

High Tide gains access to Daily High Club’s over 15,000 subscription box members who are ideal customers for High Tide to potentially launch cannabis subscription boxes in the event of U.S. 1 As of June 21st, 2021, based on analytics data provided by Alexa Internet, Inc. Traffic data provided by Google Analytics.

Consumption 116

Consumption Retail Events Media 116

Veriheal

MAY 30, 2023

Cancer Pain Relief With Cannabis: What the New Study Shows Utilizing data from the Quebec Cannabis Registry in Canada, researchers sought to examine the safety and effectiveness of cannabis in addressing cancer pain. Note: The content on this page is for informational purposes only and is not intended to be professional medical advice.

Medicine 98

Medicine Treatment Patients Data 98

PrestoDoctor

SEPTEMBER 6, 2023

Traditionally, prescription codeine has been prescribed for a variety of conditions, including post-operative pain, dental procedures, and chronic pain. One of the primary reasons for this shift is the growing acceptance and accessibility of cannabis as an alternative pain management option.

Chronic Pain 105

Chronic Pain Research and Development Patients Cannabis 105

United Patients Group

JUNE 8, 2023

It encourages patients to ask questions, provide accurate information, and participate in shared decision-making, leading to better treatment adherence and overall care quality. It replaces traditional paper-based forms and manual data entry, improving efficiency, accuracy, and patient experience. It also fosters active engagement.

Patients 52

Patients Data Collective Environment 52

Cannabis Law Report

AUGUST 10, 2021

The approval, made through the European Commission Decision Reliance Procedure (ECDRP), is based on data from a positive Phase 3 safety and efficacy study evaluating 25 mg/kg/day of GW’s cannabidiol. ADDITIONAL INFORMATION. For more information, please visit www.jazzpharmaceuticals.com and follow @JazzPharma on Twitter.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

CannaMD

SEPTEMBER 15, 2020

MORE DETAILS: On June 16, 2014, Florida became the 22nd state to legalize (at least partial) access to medical marijuana when Governor Rick Scott signed the Compassionate Medical Cannabis Act of 2014. SHORT ANSWER: Full-time and seasonal Florida residents who suffer from an eligible medical condition. ” Translation?

Law 126

Law Marijuana Patients Treatment 126